Doing Good and Building Up Merit
How can I contribute to the mathematics program at Sun Yat-sen University?
Shen Qi's method was very direct: he gave money.
For any student or faculty member of Sun Yat-sen University who achieves a Category A achievement in mathematics, a reward of 10 million RMB will be given for each achievement.
Category B achieves 5 million, Category C achieves 1 million.
The A, B, and C levels were set by Shen Qi. The difficulty of math achievements in category A is slightly lower than that of the Millennium Prize Problem, and so on for categories B and C.
Soon, this incentive program was extended to another Double First-Class university in Nangang City, Southern University of Science and Technology.
Soon after, this reward program was extended to the entire South China region.
Soon after, this reward program was rolled out nationwide.
At Shen Qi's suggestion, Shen Qi's father, Shen Zhishan, established the "Shen Zhishan Mathematics Foundation." This foundation plans to distribute 200 million RMB annually to support young Chinese mathematicians who are dedicated to contributing to the cause of mathematics in China.
At the same time, Shen Zhishan donated RMB 100 million in his personal capacity to organizations such as the Nangang Red Cross Society, the Nangang Charity Association, and the Nangang Disabled Persons Association to support charitable causes.
Shen Zhishan declared that the Shen Family's support for scientific and charitable causes would become a regular practice, winning widespread praise from the outside world.
Shen Zhishan's generosity is mainly due to the influence of Shen Qi.
"Every year, we spend hundreds of millions to support scientific research and do charity. Our Shen Family's wealth will be squandered in a few years." Shen Zhishan is, after all, a businessman. A businessman's principle for doing good deeds is to do his best as long as there is sufficient profit.
Shen Qi had a very open-minded view. "You can't take money with you when you die, but doing more good deeds will leave you with a lasting reputation."
"I fully support doing good deeds, but doing good deeds requires money! According to your charitable plan, all of our Ou Beiqi Pharmaceutical's annual profits will be donated to charity," Shen Zhishan said, then added, "Anyway, Ou Beiqi Pharmaceutical will be yours in the future, so you can do whatever you want with it. I only have one request: don't sell the factory, and give our factory's employees a way to make a living."
"Dad, I'm not stupid. Let me give you a simple math problem. Suppose our factory makes ten yuan in profit every year, it's not unreasonable for us to donate one yuan to charity, right? The factory's profitability determines the extent of our charitable acts."
"But the impression you give me is that you're going to use all ten dollars to do charity."
"Dad, do you remember the Pound Sterling 70 billion deal I told you about?"
"Sell Kang Shun?"
"Sell it."
"Can it really sell for 70 billion Pound Sterling?"
"Considering global sales, risk assessment, and patent protection, even if it doesn't reach 70 billion Pound Sterling, it should at least reach 30 billion Pound Sterling. How much is 30 billion Pound Sterling in RMB? Enough to support the factory for many years, right?"
Who will negotiate this?
"Of course, Dad, you should handle the negotiations. Old Yan and Cheng Haonan will assist you with the technical aspects, and I will support you morally."
After Shen Qi finished speaking, he went to give a lecture to the local government officials in Nangang.
Shen Zhishan became even more determined to sell Kang Shun.
The diabetes drug Kang Shun was developed by Shen Qi Research Center. After completing animal experiments, its patent development rights were sold to Ou Beiqi Pharmaceutical.
The subsequent clinical trials and market approval were completed by Ou Beiqi Pharmaceutical. Last year, Kang Shun's sales in China reached over one billion RMB, and this year it is expected to exceed two billion RMB.
Diabetes is a global disease, with global healthcare costs approaching $800 billion last year.
$800 billion is exactly equal to Switzerland's GDP.
It is predicted that global diabetes medical costs will exceed one trillion US dollars within five years.
This is an extremely large market.
International pharmaceutical giants had long coveted Kang Shun; around this time last year, GLK offered Pound Sterling 700 million to acquire Kang Shun.
At this time of year, the asking price for the GLK has risen to Pound Sterling 1.5 billion. However, this still falls short of the expectations of Shen Qi and his son.
Miss Walker. Lucy Walker of GLK has been staying in Nangang City recently, and she paid another visit to Shen Zhishan.
The two sides held their eighth round of formal business negotiations regarding Kang Shun.
"According to our forecast, Kang Shun's sales in China this year are expected to reach 2 billion RMB, which is approximately 250 million Pound Sterling. Therefore, Mr. Shen, the 1.5 billion Pound Sterling that GLK is offering is very sincere." Miss Lucy Miss Walker is an intelligent and studious woman. She has been in National First Prize and can already communicate fluently with Chinese people in Mandarin.
"Miss Lucy, that's not how you calculate it..." Shen Zhishan smiled slightly and politely explained his method.
That's right, Kang Shun's sales in China this year are around 2 billion RMB, and could reach as high as 2.4 billion RMB.
Last year, the figure was 700 million, and the year before it was 300 million.
Miss Lucy, you need to analyze the price increase, right?
Based on the sales growth trend of Kang Shun, it will reach 8.2 billion RMB next year and exceed 15 billion RMB the year after. 15 billion RMB is equivalent to nearly 2 billion Pound Sterling. This is only a sales forecast for the Chinese market for the next two years.
If Kang Shun is sold globally, global sales are projected to reach Pound Sterling 6.3 billion over the next two years, and this figure will continue to grow over time.
Don't doubt the accuracy of this number; it was calculated by my son, Fields Medal winner.
Of course, our Ou Beiqi Pharmaceutical, lacks overseas sales channels, which is a major obstacle to our internationalization efforts.
GLK has a mature and comprehensive experience in new drug application and a wide sales channel worldwide.
The European Union's drug review process is slightly stricter than that of the CDFA, while the US FDA is even more stringent.
Given that GLK needs to do a lot of work to register and sell Kang Shun globally, it also requires a significant financial investment in terms of cost.
Therefore, we at Ou Beiqi Pharmaceutical will offer our utmost sincerity by selling Kang Shun to GLK for a bargain price of Pound Sterling 70 billion.
Miss Lucy, what do you think?
Miss Lucy waved. "Bye-bye."
So Miss Lucy's negotiation team left.
"I also think 70 billion Pound Sterling is unreliable. What does 70 billion Pound Sterling mean? It's enough to start a local war! If you convert 70 billion Pound Sterling to RMB, I, Old Shen, will probably be put on a watch list by the relevant departments." Shen Zhishan said to Old Yan and Cheng Haonan.
Old Yan and Cheng Haonan, being tech-savvy, remained relatively calm and rational. "Chairman Shen, I feel that the British girl is wavering a bit. She should contact us again in a few days."
Sure enough, two days later, Miss Lucy came again. "Mr. Shen, GLK headquarters has decided that we will offer Pound Sterling 8 billion to acquire all shares of Ou Beiqi Pharmaceutical. This is our bottom line. We'll talk if we can, and if not, we'll still be friends."
Shen Zhishan waved. "Bye-bye."
That's how business negotiations are; both sides use their wits and are meticulous in their calculations, and it's hard to know when it will ever end.
Acquisitions in the pharmaceutical industry are almost synonymous with astronomical sums.
Back in 2000, Pfizer spent $90 billion to acquire Warner-Lambert, thus obtaining Lipitor as it had hoped.
Decades have passed, and prices have risen. Today, to make a business acquisition similar to Warner-Lambert or Lipitor would require at least a hundred billion dollars.
GLK has offered Pound Sterling 8 billion to acquire Ou Beiqi Pharmaceutical.
Shen Zhishan and Shen Qi would never agree to it.
Selling medicine, not the factory, is the bottom line for the Shen Family.
Shen Qi concluded his nationwide speaking tour and returned to the capital.
The Phase I clinical trial of Triazatrisiloxanes has been completed, and the next step is to enter the Phase II clinical trial.
A new drug becomes valuable once animal testing is completed.
Successfully completing Phase I clinical trials will multiply its value.
Its value has increased with each Phase II and III clinical trial.
If it is successfully launched and achieves remarkable sales results, it can generate astronomical sales figures.
This is why Shen Qi and his son would never sell Ou Beiqi Pharmaceutical; the factory is their root, their solid foundation.
Chemical drugs are, simply put, a series of compounds.
If the stronghold remains, and outstanding talents gather, new compounds can be continuously invented and created.
"Did you go back to your hometown of Nangang and become a money-giving boy?" Ou Ye asked.
"Supporting young and ambitious mathematicians has always been my wish. I don't want to see Abel's tragic story happen in our time. Doing charity is something I'm happy to try. Honey, you won't disagree, will you?"
"Of course I agree! I want to support mathematicians and do charity work with you. We have some money in our account, let's use it."
"Don't touch the money at home; save it for Nofi's education. If the deal with Ou Beiqi Pharmaceutical goes through, take a portion of that money and do charity."
"Okay, whatever you say. Qi, go take a shower."
"It's only seven o'clock! We just finished eating and haven't even digested yet... Let's go later..."
Shen Qi, who had advanced to level 12 in physical education, barely managed to hand in his assignment.
If we don't reach level 12, someone might die.
Triazatrisiloxanes is really potent; Ou Ye's abilities improved dramatically after taking it.
Shen Qi himself wished he could take several kilograms of Triazatrisiloxanes to boost his nutrition.
The couple is very happy in their married life, and in every way, Ou Ye is full of energy and devoted to her work.
It has been two weeks since Ou Ye attended an academic exchange meeting organized by Academician Su Wenxie at Shuimu University.
Today marks exactly two months since Ou Ye published his "Strong BSD Conjecture Proof".
Academician Su Wenxie's mathematics team announced today that they have provided a reasonable explanation for the Strong BSD Conjecture Proof by Ou Ye's team, and released an explanation report of more than 800 pages.